Role of CA19-9 in the prognostic evaluation of SOX neoadjuvant chemotherapy for gastric cancer.

Liu, Xiaozhen; Meng, Xuli; Li, Yongfeng; Chai, Wubin; Qian, Jiacheng; Tang, Hongchao

Liu, Xiaozhen; Meng, Xuli; Li, Yongfeng; Chai, Wubin; Qian, Jiacheng; Tang, Hongchao.

Afiliación

Liu X; Clinical Sample Bank, Zhejiang Cancer Hospital Hangzhou 310022, China.
Meng X; Department of General Surgery, Tongde Hospital of Zhejiang Hangzhou 310012, China.
Li Y; Department of Breast Surgery, Zhejiang Cancer Hospital Hangzhou 310022, China.
Chai W; Department of The Second Surgery, Daishan First People's Hospital Zhoushan 316200, China.
Qian J; Zhejiang Chinese Medical University Hangzhou 310053, China.
Tang H; Department of General Surgery, Zhejiang Hospital Hangzhou 310013, China.

Int J Clin Exp Pathol ; 11(11): 5387-5393, 2018.

Article en En | MEDLINE | ID: mdl-31949620

Palabras clave

CA19-9; SOX; gastric adenocarcinoma; neoadjuvant chemotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Int J Clin Exp Pathol Asunto de la revista: PATOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google